Menu

Meet the First Artificial Embryo Made From Stem Cells

Researchers report growing a mouse embryo using two types of early stem cells.

Mar 2, 2017
Bob Grant

A stem cell-modeled mouse embryo at 96 hours (left); Mouse embryo cultured in vitro for 48 hours from the blastocyst stage (right). The red part is embryonic and the blue extra-embryonic.IMAGE: SARAH HARRISON AND GAELLE RECHER, ZERNICKA-GOETZ LAB, UNIVERSITY OF CAMBRIDGEScientists claim to have created an artificial mouse embryo using two types of stem cells—embryonic stem cells and extra-embryonic trophoblast stem cells, which normally form the placenta. They reported their results in Science yesterday (March 2).

“They are very similar to natural mouse embryos,” lead author Magdalena Zernicka-Goetz, a University of Cambridge biologist, told New Scientist. “We put the two types of stem cells together—which has never been done before—to allow them to speak to each other. We saw that the cells could self-organize themselves without our help.”

Zernicka-Goetz and her colleagues placed the mixture of embryonic and trophoblast stem cells onto a 3D scaffold that mimicked the extracellular matrix and aided in the nascent cells’ development. Four and a half days later, the group of cells on the scaffold had architecture and morphogenesis resembling a natural mouse embryo.

Scientists may be able to use similar methods to grow and study early human embryos. “This will allow us to study key events of this critical stage of human development without actually having to work on embryos,” Zernicka-Goetz told Reuters. “(And) knowing how development normally occurs will allow us to understand why it so often goes wrong.”

That proposition, of course, raises myriad ethical questions. Currently, developmental biologists can only use discarded human embryos and can only keep them alive for 14 days, post fertilization. “A regulatory body will ultimately decide on whether human stem cell embryos can be generated and for how long they can be left in the petri dish to develop further,” James Adjaye, a stem cell researcher at Heinrich Heine University in Germany, told The Telegraph. “Of course, there should be an international dialogue on the regulation of such experiments.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.